Results 51 to 60 of about 690,170 (210)

Carcinoid heart disease [PDF]

open access: yesCurrent Cardiology Reports, 2006
Progress in the medical and surgical management of patients with carcinoid disease has resulted in improved symptoms and survival. Carcinoid heart disease remains a major cause of morbidity and mortality among patients with malignant carcinoid syndrome.
Patricia A. Pellikka, Heidi M. Connolly
openaire   +5 more sources

Carcinoid Heart Disease

open access: yesJournal of the American College of Cardiology, 2010
![Figure][1] [![Graphic][3] ][3][![Graphic][4] ][4][![Graphic][5] ][5] A 26-year-old man with a history of carcinoid and small-bowel resection presented with shortness of breath.
Susie N. Hong   +2 more
openaire   +3 more sources

European Neuroendocrine Tumor Society (ENETS) 2022 Guidance Paper for Carcinoid Syndrome and Carcinoid Heart Disease

open access: yesJournal of neuroendocrinology, 2022
Carcinoid Heart Disease Clinic, Department of Cardiology, Royal Free Hospital & University College London, London, UK Department of Internal Medicine, Section of Endocrinology, ENETS Center of Excellence, Erasmus MC and Erasmus Cancer Institute ...
S. Grozinsky-Glasberg   +13 more
semanticscholar   +1 more source

Carcinoid heart disease in patients with midgut neuroendocrine tumours

open access: yesJournal of neuroendocrinology, 2023
Carcinoid heart disease (CHD) is the main complication of carcinoid syndrome (CS) associated with metastatic small intestine neuroendocrine tumours (NETs).
C. Delhomme   +11 more
semanticscholar   +1 more source

The role of N‐terminal pro‐brain natriuretic peptide, chromogranin A, and 5‐hydroxyindoleacetic acid in screening for carcinoid heart disease

open access: yesJournal of neuroendocrinology, 2023
Carcinoid heart disease (CHD) is a serious complication for patients with neuroendocrine tumors (NETs), and early detection is crucial. We aimed to investigate N‐terminal pro‐brain natriuretic peptide (NT‐proBNP), chromogranin A (CgA), and plasma 5 ...
Karen Kristina Nyvold Johnson   +7 more
semanticscholar   +1 more source

Patent foramen ovale in carcinoid heart disease: The potential role for and risks of percutaneous closure prior to cardiothoracic surgery

open access: yesJournal of neuroendocrinology, 2023
Neuroendocrine tumours (NETs) are rare but once metastasised, can lead to the release of vasoactive substances into the systemic circulation, and the classical features of carcinoid syndrome (CS) such as flushing and diarrhoea.
Sasha Douglas   +5 more
semanticscholar   +1 more source

Biochemical factors in the blood serum of neuroendocrine tumor patients with carcinoid syndrome

open access: yesУспехи молекулярной онкологии, 2022
Introduction. Carcinoid syndrome is the most common functional syndrome in patients with neuroendocrine tumors. More than 40 biochemical factors are responsible for the manifestation of carcinoid syndrome, among which serotonin is the most important. The
N. V. Lyubimova   +5 more
doaj   +1 more source

Primary Testicular Carcinoid Tumor presenting as Carcinoid Heart Disease

open access: yesIndian Journal of Urology, 2015
Primary carcinoid tumors of the testis are very rare, and they seldom present with carcinoid syndrome. We report a hereto unreported instance, where a patient with a long-standing testicular mass presented with carcinoid heart disease, an uncommon form ...
Manjunath L Chikkaraddi   +2 more
doaj   +1 more source

The association of a panel of biomarkers with the presence and severity of carcinoid heart disease: a cross-sectional study.

open access: yesPLoS ONE, 2013
PurposeMetastatic neuroendocrine tumors secrete serotonin and other vasoactive substances that are responsible for carcinoid syndrome and carcinoid heart disease.
Rebecca Dobson   +15 more
doaj   +1 more source

Carcinoid Heart Disease in Patients With Bronchopulmonary Carcinoid [PDF]

open access: yesJournal of Thoracic Oncology, 2018
The prevalence of carcinoid heart disease (CaHD) in bronchopulmonary carcinoid and its relationship with left-sided valvular disease are unknown.All patients with a pathologic diagnosis of bronchopulmonary carcinoid and echocardiography performed at our institution between 2001 and 2016 were retrospectively reviewed.
De Jesus, Tais   +6 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy